Accepted for Publication: June 22, 2011.
Published Online: August 15, 2011. doi:10.1001/archdermatol.2011.232
Author Contributions: Drs Raphael, Suchin, and Rook had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Raphael, Suchin, Kim, and Rook. Acquisition of data: Raphael, Suchin, Morrissey, Kim, Gardner, Evans, Introcaso, Samimi, and Rook. Analysis and interpretation of data: Raphael, Shin, Suchin, Morrissey, Vittorio, and Gelfand. Drafting of the manuscript: Raphael, Suchin, Morrissey, and Rook. Critical revision of the manuscript for important intellectual content: Shin, Morrissey, Vittorio, Kim, Gardner, Evans, Introcaso, Samimi, and Gelfand. Statistical analysis: Raphael, Shin, and Gelfand. Obtained funding: Rook. Administrative, technical, and material support: Suchin and Vittorio. Study supervision: Suchin, Evans, Introcaso, and Rook.
Financial Disclosure: Dr Kim is an investigator for Ten X Pharmaceuticals, Biocryst, Gloucester, Centocor, and Yaupon and a consultant for Eisai. Dr Rook is a consultant for Hy Bio Pharma and has lectured for Therakos.
Additional Contributions: We are indebted to the rest of the Cutaneous T-Cell Lymphoma staff, including Barbara DeNardo, RN, William Macey, RN, MS, Patricia Bromley, RN, Joanne Inverso, RN, Mia Perry, RN, and Barbara Pratt, BA.